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EXECUTIVE SUMMARY 
 
The Ministry of Health and Social Services (MOHSS) periodically conducts several different supervisory 
and survey activities designed to help identify the gaps and successes of program implementation at 
all sub-national levels. The MOHSS HIV Drug Resistance Surveillance 2014 Early Warning Indicator 
(EWI) Report identified several quality gaps of ART services. Of major concern were the gaps in Viral 
Load (VL) measurement and the suppression rates after treatment initiation. Supply chain 
interruptions were also identified in several sites as well as gaps in retention in care and treatment 
adherence.  Many of these concerns were also partly identified during the MOHSS Technical 
Supervisory Support Visits (TSSV) 2013 Report. Furthermore consultations conducted during the 2013 
National Strategic Framework for HIV/AIDS response (NSF) mid-term review as well as the 
development of the National ART Operational Plan 2014/15- 2016/17 identified similar concerns with 
quality gaps in some ART facilities. In order to develop a deeper understanding of the quality of ART 
services in several of Namibia’s ART facilities, the MOHSS in collaboration with the US Centres for 
Disease Control and Prevention (CDC) conducted the ART Service Quality Assessments (SQA) in 14 
facilities from 7 high HIV burden regions of Namibia during the month of December 2014.The main 
goal of the SQA was to conduct a standardized, in-depth assessment of ART clinical care provided at 
the sites with the following specific objectives: 
 
i. Assess site processes that support quality of clinical care  
ii. Assess adequacy of documentation of outcomes and processes  
iii. Assess compliance and implementation of national guidelines  
iv. Identify site barriers to providing high quality clinical care 
 
A SQA is an in-depth assessment of service delivery quality for HIV treatment services against national 
programmatic standards.  As such, it provides aggregate data and analysis to inform programmatic 
improvement in ART clinical services, it helps identify areas for further assessment and improvement 
and it can be used as an opportunity to build capacity for future site level service quality assessments. 
 
The key findings from the SQA: 
The assessment identified several key strengths in ART service delivery, among them-ongoing efforts 
to provide ART closer to patients through IMAI/NIMART and outreach clinics; strong provider 
understanding of patient follow up intervals; supply chain reliability as well as consistent prescription 
of adult and pediatric cotrimoxazole. 
 
Overall the ePMS showed significantly incomplete documentation of lab results. The greatest disparity 
in documenting lab results was with Viral Load (VL) results. Only half of the patients who had a VL 
result recorded in the Patient Care Booklet (PCB), had the result also captured in the ePMS (72% vs 
36% receptively). This potentially has significant implications in our capacity to accurately monitor VL 
outcomes (the last 90 in the 90:90:90) using ePMS data centrally. 
 
In terms of meeting quality standards for key clinical domains, the assessment demonstrated major 
gaps in the following 6 domains: Pediatric ARV supply chain, Pediatric TB Screening, Routine Screening 
for HIV testing for children, Adolescent Support Services; Pediatric Facility Referral to Community Care 
and Support Services and Pediatric Growth Monitoring. 
 
The review of facility level staffing data suggests rapid turnover of physicians and pharmacists in the 
ART sites with only about 30% of these cadres having served in the sites for more than 2 years. This is 
likely linked to the general shortage of these cadres across the hospital services such that many are 
  
rotated from ART services to other divisions. Registered nurses provide some continuity in the sites 
with about 52% reporting having been at the sites for more than 2 years. Data clerks, lab technicians 
and lay counselors have the least turnover with majority having served the sites for 2-5 years or more. 
This data showing rapid turnover of physicians and pharmacists from ART sites but more stability 
among nurses and other cadres further supports the Government of the Republic of Namibia (GRN) 
strategy of scaling up Nurse Initiated Management of Antiretroviral Therapy (NIMART) which aims to 
build the capacity of registered nurses to initiate and manage ART patients. 
 
In terms of VL monitoring key gaps were identified in pediatric VL testing showing <80% of patients 
had VL testing within 8-12 months of ART initiation. Similarly major gaps were identified in pediatric  
viral load suppression rates (<70%).Out of the total 116 pediatric patient charts reviewed ; only 50% 
had viral load measurement done within the recommended 6-9 months after ART initiation. Only 60% 
of those children who had VL measurement also showed suppression (<1000 copies/ml of blood). 
The assessment also identified major challenges in supervisory support visit provided to ART sites and 
this can negatively influence quality of service delivery and staff motivation .50% of the sites reported 
either no supervisory visit from higher level within the past 3 months or visits that were not regular 
enough during the last 12 months. The critical benefit of regular site-level supportive supervision must 
be acknowledged in ART service and necessary logistic and financial commitment must be made to 
implement it accordingly. 
 
Key Recommendations of the SQA: 
Given the challenges of retention, difficulties faced by patients to travels to ART clinics at major 
hospitals and health centres, the MOHSS should continue rapidly scaling up NIMART; a strategy which 
empowers nurses to initiate and manage ART patients even at primary care clinics throughout the 
country. 
 
Review of staffing data revealed notable disparities’ in available staff resources for ART services 
between sites (doctors, registered nurses and data clerks). In view of general staff shortages for ART 
services there is need to ensure equity in future staff resource distribution across the different types 
of staff cadres (taking into account the patient load e.g. Workload Indicators for Staffing Needs (WISN) 
data, level of facility and unique considerations of the geographic location of the site). Furthermore 
frequent staff rotations at ART clinics often left the clinics with staff not well trained or experienced 
in ART provision. It is therefore important for health managers at district and facility level to ensure 
that when rotating staff-there has to be a purposeful plan to ensure that at any given time-there is 
always someone with experience in ART management working at the ART clinic. This will ensure 
bridging during transitions and avoid situations where the clinic is completely manned by all new staff 
when all experienced staff have been rotated out of the ART clinic. Regarding staff training in particular 
HIV trainings, clinical and nurse mentors should use the data on training gaps to identify topics for 
onsite mentoring and training. Furthermore given the limited opportunities for workshop setting 
trainings; other platforms such as Digital Video Conferencing (DVC) and Project ECHO® should 
consider the data on training gaps to identify topics that can be covered through these training 
platforms. 
 
Disruptions of ARV supplies were reported in several facilities due mainly to outages at the national 
level. Given the potential hazards such stock outages may have on patient ART adherence; risk of 
development of treatment failure and HIV drug resistance, it is therefore critically important to 
improve National level adult ARV supply chain reliability. 
Several facilities had no systems in place to quickly identify and track patients who missed their follow 
up visits. It is there important for facilities to develop and implement systems (including SOPs) and 
  
system to track and document outcomes for patients who miss scheduled visits using data (ePMS or 
EDT queries) including collaboration with Community-based organizations. 
 
The three most common suggestions made by health workers on ways to improve patient retention 
in care were reducing waiting time in clinics, strengthening staff training and expansion of ART services 
to where they are needed most.This includes developing and implementing innovative strategies to 
lessen the burden of transportation on patients coming for regular clinical reviews and/or pill pick up. 
 
Regarding the suboptimal VL monitoring particularly for pediatric patients ,it is also very important to 
provide mentorship and implement QI to improve VL testing rates as well as implementing facility 
strategies to enhance adherence and improve VL suppression rates. These may include provision of 
ART medicines for more than one month scripts for stable patients and consider other proven 
interventions such as Community-based ART distribution (e.g. Community outreach points). 
Data quality issues were also identified as a major challenge through this assessment. Overall-there is 
an urgent and critical need to improve the completeness of the documentation of lab results in the 
ePMS. Given that VL results are now the pivotal lab result for monitoring both clinical and 
programmatic performance –there is need to ensure that these VL results data are completely 
documented and validated in both the PCBs and the ePMS.
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1 INTRODUCTION 
The Ministry of Health and Social Services (MOHSS) began an antiretroviral treatment (ART) 
programme as part of the programme for PMTCT in 2002. Technical guidelines and trainings 
were rapidly developed and ARVs services outside the PMTCT setting were piloted in 2003. 
According to the Namibia National Strategic Framework (NSF) for HIV and AIDS 2010/11 to 
2015/16, the expected outcomes for the National Case Management (ART and Care) 
programme are for to ensure that more PLHIV survive longer on ART, and cared for in their 
communities and that more PLHIV with TB co-infection are successfully treated. The Namibia 
National Strategic Framework for HIV/AIDS Response (NSF) identifies several key strategic 
actions for the Case Management programme which include: 
 Improving ART coverage as well as the service provision environment including human 
resource and infrastructure capacities 
 Encouraging adherence to treatment schedules to minimize defaulters and drug 
resistance over time 
 Enhancing quality of care by managing treatment standards 
 Strengthening linkages across key response areas for treatment care and support, 
particularly referral to the ART program and the management of OIs 
 Developing a more reliable monitoring and tracking systems for ART patient 
management 
 Strengthening the pharmaceutical supply system throughout all the levels of the 
supply chain 
 Improving coordination and harmonization of the service delivery of Community 
Home Based / palliative Care 
 Strengthening coordination between HIV and TB so that more PLHIV with TB are 
successfully treated 
 Scaling up implementation of the Three I’s strategy 
In order to monitor progress in the implementation of these key strategic, the MOHSS 
through the Directorate of Special Programs (DSP) periodically conducts several different 
supervisory and survey activities designed to help identify the gaps and successes of program 
implementation at all sub-national levels. The MOHSS HIV Drug Resistance Surveillance 2014 
Early Warning Indicator (EWI) Report identified several quality gaps of ART services. Of major 
concern were the gaps in Viral Load (VL) measurement and the suppression rates after 
treatment initiation. Supply chain interruptions were also identified in several sites as well as 
gaps in retention in care and treatment adherence.  These concerns were also partly identified 
during the MOHSS Technical Supervisory Support Visits (TSSV) 2013 Report. Furthermore 
consultations conducted during the 2013 NSF mid-term review as well as the development of 
the National ART Operational Plan 2014/15- 2016/17 identified similar concerns with quality 
gaps in some ART facilities. 
In order to develop a deeper understanding of the quality of ART services in several of 
Namibia’s ART facilities, the MOHSS in collaboration with the US Centres for Disease Control 
and Prevention (CDC) conducted the ART Service Quality Assessments (SQA) in 14 facilities 
from 7 high HIV burden regions of Namibia during the month of December 2014. 
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1.1 SQA Goals  
The main goal of the SQA was to conduct a standardized, in-depth assessment of ART clinical 
care being provided at the sites with the following specific objectives: 
v. Assess site processes that support quality of clinical care  
vi. Assess adequacy of documentation of outcomes and processes  
vii. Assess compliance and implementation of national guidelines  
viii. Identify site barriers to providing high quality clinical care 
2 METHODS  
Service Quality Assessment (SQA) is an in-depth assessment of service delivery quality for HIV 
treatment services against national and PEPFAR programmatic standards.  As such, it provides 
an aggregate data and analysis to inform programmatic improvement in ART clinical services, 
it helps identify areas for further assessment and improvement and it can be used as an 
opportunity to build capacity for future site level service quality assessment. 
The service quality assessment (SQA) of ART (adult and pediatric) was conducted at each of 
the sites visited. National guidelines were used to inform the ART standards of care against 
which sites were assessed. This analysis focused on the following domains: 
 
I. Medication management 
II. Laboratory management 
III. TB/HIV screening and infection control 
IV. Quality management and improvement (QM/QI) 
V. Medical records 
VI. Site supervision and mentoring 
VII. Community linkages 
VIII. Supply chain management 
IX. System processes for ART services (appointment retention, adherence, viral 
load management) 
 
2.1  Sampling process 
A total of 14 sites providing ART services as of the FY 2014 PEPFAR semi-annual report were 
purposively selected for the SQA activity. Sites were selected on terms of logistic feasibility 
and the representation of clinic size, regional support to the MOHSS by CDC, and type of 
facility.  
Eligible adult patients included those who had been on ART 24-36 months and eligible 
pediatric patients had been on ART for a minimum of six months; excluding those dead, lost, 
or transferred from the clinic. From the total number eligible, every “x” number of patients 
was selected per site to select 15 adult and 10 pediatric patients per site. 
The following table shows the list of regions and particular ART sites included in the SQA with 
respective data on currently active ART patients (September 2014), the number of patients 
(adult and pediatric) who were eligible for review, and the number of charts reviewed for 
each ART site.  
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Table 2-1 List of health facilities included and sample of patient records reviewed in the SQA 
 
Site Region Current 
patients 
on ART 
Eligible 
pediatric 
ART 
patients 
Number of 
pediatric 
ART charts 
reviewed 
Eligible 
adult ART 
patients 
Number of 
adult ART 
charts 
reviewed 
Engela Ohangwena 4889 33 10 393 15 
Katima Mulilo Zambezi 3526 64 10 393 15 
Katutura HC Khomas 6144 14 10 717 15 
Katutura Hospital Khomas 6734 22 10 321 15 
Khomasdal HC Khomas 895 0 0 99 14 
Nankudu Kavango 895 3 2 61 14 
Okalongo HC Omusati 2899 22 5 155 15 
Onandjokwe Oshikoto 9271 46 9 581 15 
Ongwediva HC Oshana 1850 5 10 128 15 
Oshakati Oshana 8127 40 10 630 15 
Oshikuku Omusati 3970 18 10 206 15 
Outapi Omusati 6822 97 10 864 15 
Rundu Kavango 4318 82 10 741 15 
Tsandi Omusati 1630 12 10 127 15 
TOTAL    116  208 
 
2.2  Data Handling and Analysis 
The Ministry of Health and Social Services (MOHSS), the Centers for Disease Control and 
Prevention (CDC) Namibia, United States Agency for International Development (USAID), US 
Health Resources and Services Administration (HRSA), Management Sciences for Health 
(MSH), International Training and Education Center for Health (ITECH) and CDC Headquarters 
(HQ) participated in the data collection process while data analysis was conducted by CDC HQ 
in Atlanta.  
2.3  Data collection 
Data was collected through semi-structured interviews with providers, nurses, lab 
technicians, data clerks, social workers, pharmacy, and social workers at selected ART clinics. 
Interview question responses were select one, select all, and open ended. Additionally, adult 
and pediatric charts were reviewed at each clinic. The patient’s paper record (patient 
booklet), their electronic record (ePMS), and their viral load results within MEDITECH were 
reviewed and data was recorded, when available.  
2.4 Data analysis 
Data collected from interviews and patient charts was entered, by site, into Microsoft Excel 
spread sheets after each site visit was conducted. After all site visits were conducted, site-
level data was aggregated, cleaned, and descriptive analyses were conducted by CDC HQ. 
Semi-structured interviews 
Interviews were conducted by each team with a variety of ART clinical staff at each site. Team 
members discussed their findings and submitted the site’s final responses for data analysis. 
Qualitative responses were coded through inductive reasoning by the CDC HQ team. 
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ART patient chart review 
Adult ART 
For data validation and quality purposes, data from the patient booklet (N=118) and ePMS 
(N=118) for eight (8) sites was compared: Engela; Katima Mulilo; Katutura Health Centre; 
Intermediate Hospital Katutura; Khomasdal Health Centre; Nankudu; Onandjokwe; and 
Rundu.  
For patient care analysis, data from all 14 sites (N=208) was utilized. The source document  is 
patient booklet for eight (8) sites: Engela; Katima Mulilo; Katutura Health Centre; 
Intermediate Hospital Katutura; Khomasdal Health Centre; Nankudu; Onandjokwe; and 
Rundu, and combined data from patient booklet and ePMS for six (6) sites: Okalongo Health 
Centre; Ongwediva Health Centre; Oshakati; Oshikuku; Outapi; and Tsandi. Data collection in 
these six sites was conducted in such a way that a distinction could not be made for the data 
source (ePMS versus patient booklet). The source document was chosen to give the most 
accurate clinical data for each patient. 
 
Pediatric ART 
For data validation and quality purposes, site-level information from two data sources was 
analyzed. This includes the patient booklet (N=60) and ePMS (N=60) for six (6) sites: Engela; 
Katima Mulilo; Katutura Health Centre; Intermediate Hospital Katutura; Onandjokwe; and 
Rundu. 
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3 RESULTS 
In the following section the key SQA results are summarized mainly through figures with 
accompanying brief narrative descriptions. More detailed results are shown in tabular form 
in the appendices section of this report. 
3.1 Overview of scorecard analysis for all sites 
Table 3-1 Overview of Scorecard Analysis by Site 
Site number* 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Adult/Adolescent care and treatment                             
Patient tracking Y R Y R Y R R DG Y R R DG Y R 
Adherence support DG DG LG DG LG LG DG DG DG DG LG LG LG LG 
ART monitoring adult DG R DG DG DG LG LG LG DG DG DG DG LG DG 
 Supply chain reliability (ARVs) Y DG R LG DG R LG R R DG LG LG R R 
Reference materials DG DG DG LG DG R LG DG DG DG DG DG DG DG 
Adult care and support                             
Cotrimoxazole DG DG DG DG DG DG DG DG DG DG DG DG DG DG 
Facility linkage to community care and support R R R R R R R R R R R R R R 
Supply Chain Reliability Cotrimoxazole (CTX) DG DG DG DG DG DG DG R DG DG DG DG DG DG 
PHDP LG R LG DG DG R R LG R R Y R R R 
Food and nutrition                             
Pediatric growth monitoring 0 Y R R R R R R R R Y Y R R 
Laboratory                             
Testing interruptions Y R DG DG DG DG 0 DG 0 Y LG R Y Y 
Results and information management DG DG DG DG DG Y 0 DG 0 DG LG LG DG LG 
Medication management                             
Supply chain management   DG DG DG LG LG 0 LG DG DG DG DG DG LG DG 
Medication dispensing DG Y LG LG R LG LG DG LG DG LG DG LG LG 
Pediatric care and treatment                             
Pediatric ART eligibility DG DG DG LG Y LG DG DG DG DG LG LG DG LG 
Pediatric ART monitoring DG Y DG LG DG Y DG DG LG DG DG DG LG DG 
Supply chain reliability (pediatric ARVs) Y DG DG LG R R DG Y DG DG DG DG R R 
Supply chain reliability (pediatric cotrimoxazole) DG DG DG DG DG DG DG R DG DG DG DG DG DG 
Pediatric cotrimoxazole DG LG DG DG DG DG DG DG DG DG DG DG DG DG 
Dosing of pediatric ARVs DG DG DG DG DG DG DG DG DG DG DG DG DG DG 
Pediatric TB screening DG DG DG LG LG Y DG DG DG DG R R DG R 
Routine HIV testing for children R R R R R R 0 R 0 R R R R R 
Adolescent support services DG Y R DG R R R DG 0 LG R R DG R 
Pediatric facility referral to community care and support 
services 
R R R R R R R R R R R R R R 
TB/HIV                             
Adult/Adolescent TB screening DG LG DG LG DG LG DG DG DG DG R LG R R 
Isoniazid Preventive Therapy (IPT) 0 R LG Y R R LG Y R LG R Y R LG 
Site/performance management (ART)                             
Supportive supervision Y Y R R Y R LG R DG LG R R DG R 
Site/performance management (ART – QM/QI system)                             
HIV QM/QI System LG R LG DG Y Y Y R DG R R LG Y Y 
Assessment and Utilisation of Performance Data R R Y LG Y Y R R Y LG R Y Y Y 
*Site names: (1) Engela; (2) Katima Mulilo; (3) Katutura Health Centre; (4) Katutura 
International Hospital; (5) Khomasdal Health Centre; (6) Nankudu; (7) Okalongo Health 
Centre; (8) Onandjokwe; (9) Ongwediva Health Centre; (10) Oshakati; (11) Oshikuku; (12) 
Outapi; (13) Rundu; (14) Tsandi. 
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3.2 Adult /Adolescent Care and Treatment 
 
Figure 3-1 Adult/Adolescent Care and Treatment: Aggregate Site Performance per Domain 
The aggregate results in Figure 3-1 (see also Table 1 in appendices) show that the Adherence 
Support, Adult ART Monitoring and Reference Materials domains in most facilities visited 
largely met or exceeded the standards. However key gaps were identified in patient tracking 
(50%) and ARV supply chain reliability (43%). 
 
3.3 Pediatric care and treatment 
Figure 3-2 shows that pediatric ART eligibility, Pediatric ART monitoring, Pediatric 
Cotrimoxazole, Pediatric Cotrimoxazole Supply Chain (93%) and Dosing of Pediatric ARVs 
(100%) either met or exceeded the minimum standards. There were very minimal 
interruptions in supply chain reliability for Pediatric Cotrimoxazole (7%). 
Figure 3-2 and Figure 3-3 however show key gaps in Pediatric ARV supply chain (29%) , 
Pediatric TB Screening (21%),Routine Screening for HIV testing for children (100%),Adolescent 
Support Services (54%); Pediatric Facility Referral to Community Care and Support Services 
(100%) and Pediatric Growth Monitoring (77%) 
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Figure 3-2 Paediatric Care and Treatment (1) 
 
 
 
Figure 3-3 Paediatric Care and Treatment (2) 
 
3.4 Food and Nutrition/Pediatric growth monitoring  
Table 3-2 (see appendices section) shows that 77% of the sites did not have documentation of 
anthropometric assessment (i.e. weight and length or height, BMI, MUAC, or growth monitoring 
curve) during the last clinical visit per national guideline. The remaining 23% of facilities had some 
documentation on nutritional assessment. 
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3.5 Adult care and support  
In terms of Adult Care and Support Figure 3-4 shows that there was 100% prescription of Adult 
Cotrimoxazole (CTX) across all sites assessed. Interruptions of Supply Chain for Adult CTX were 
very minimal (7%).However there were no systems in place for facility linkage to community 
care and support (100%).In addition Facility-based Positive Health Dignity and Prevention 
(PHDP) activities were not implemented in the majority of facilities visited (57%). 
 
Figure 3-4 Adult Care and Support: Aggregate site performance per domain 
 
3.6 Laboratory 
Figure 3-5 Laboratory Testing Interruptions and Information Management 
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Figure 3-5 shows that  almost 60% of the sites experienced HIV testing interruptions during 
the last 3 months due to equipment failures, supply or reagent stock outs, expired supplies 
or reagents, staff shortages, or infrastructure issues. However, 17% of the facilities 
experienced shortage of supplies and reagents for core laboratory tests or were not within 
their expiration dates.92% of the facilities had standardized forms/procedures and electronic 
data management system (the Meditech) that enabled them to manage information and data 
for laboratory services. 
 
3.7 Medication management 
Figure 3-6 Medication Management 
 
 
Figure 3-6 shows that 69% of the facilities had excellent documentation on medication 
dispensing which were complete, up to date and reviewed routinely.  Medication 
management system was found to be satisfactory in the remaining 31% of the assessed 
facilities. 
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3.8 TB/ HIV 
Figure 3-7 TB/HIV 
 
 
Figure 3-7 shows that 79% of sites had standard operating procedures and algorithm for 
symptomatic TB screening of patients (cough, fever, night sweats, and weight loss at a 
minimum) attending HIV care and treatment services during their last clinical visit.   Patient 
chart reviews indicated that more than 80% of clients were symptomatically screened for 
active TB infection during their last clinic visit. 
However 46% of the sites did not have standard procedures for administration of Isoniazid 
Preventive Therapy (IPT).  23% were providing IPT services for up to 80% of the eligible 
patients while 31% of sites provided IPT for 80-99% of the eligible clients. 
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3.9 Site performance management (ART) and QM/QI system 
Figure 3-8 Site Performance Management (ART)/Supportive Supervision 
 
Figure 3-8 shows that 50% of the sites reported either no supervisory visit from higher level within the 
past 3 months or visits that were not regular enough during the last 12 months. Furthermore only 35% 
of sites reported having a functional HIV QM/QI system and only 14% of sites reported conducting 
routine site level assessments and utilization of performance data. 
 
3.10 Patient tracking  
Table 3-2 shows that 43% of sites reported interruption of ART services in the last 12 months and 57% 
of these interruptions were attributed to commodity shortages (ARVs).93% of sites had standard for 
appointing patient follow up visits; 57% of sites defined missed appointment as “same day”. 
“Transportation” was cited as the main reason for missed appointments in 86% of the responses and 
incorrect patient information (50%) as well as lack of human resources (43%) were cited as the main 
challenges faced with regard to patient tracking. 
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Table 3-2 Patient Tracking (N=14 sites) 
Characteristic N (%) 
Any interruption of ART services in the last 12 months 
                  Median number of episodes 
                  Median length of episodes 
Reason for HIV service interruption 
                  Human resource shortage 
                  Lab testing interruptions/ shortage 
                  Commodities shortages (ARVs) 
                  Other 
Standard for appointing patient follow-up visit 
                  Documentation of follow-up date in patient booklet 
                  Documentation of follow-up date in patient passport 
                  Use of appointment book 
                  Other 
When are visits appointed for following patients: 
                  After initial visit/enrolment to HIV care (# of weeks) 
                  Patients in  HIV care not eligible for ART (pre-ART) (# of weeks) 
                  After ART initiation (# of weeks) 
                  After a VL specimen is collected (# of weeks) 
                  If VL at 6 months < 1000 (# of weeks) 
                  If VL at any time is > 1000 (# of weeks) 
Definition of “missed appointment”* 
                  Same day 
                  Less than 2 weeks 
                  More than 2 weeks 
Process in place after a missed appointment* 
                  No process/ system 
                  Phone calls to patient 
                  Adherence counseling or support is provided 
How is a missed appointment identified* 
                  ePMS used to generate a list of patients 
                  Data clerk identifies patients 
                  Other 
                  Review of patient booklet* 
Individual responsible for monitoring the missed appointments: 
                  Data clerk 
                  Provider 
                  Default tracer / community counselor / community organization 
Type of patient tracking conducted when a patient misses an appointment 
                  Phone 
                  Community counselor (facility based lay counselor) 
                  Community based organization 
                  Home visit 
                  SIMS 
Patient tracking procedures are initiated: 
                  <1 month 
                  30-90 days 
                  >90 days 
Main reasons patient cite missing appointments: 
Transportation 
Work 
                  Forgot 
Not able to determine follow-up date* 
Out of town* 
Other 
Very sick 
Lack full disclosure (with partner or child)* 
Competing activities (example: funeral)* 
Feel well 
                  Child / home care responsibilities 
Outcomes are documented 
Estimated average percentage of missed patients who return to services 
                  0-25% 
                  25-50% 
                  51-75% 
                  76-100% 
Challenges faced with regard to patient tracing* 
                  Lack of human resources 
                  Incorrect patient information 
                  No system in place 
6 (43%) 
2 (2) 
1-2 weeks 
 
1 (14%) 
1 (14%) 
4 (57%) 
1 (14%) 
13 (93%) 
12 (92%) 
10 (77%) 
5 (38%) 
7 (54%) 
 
2 (6) 
12 (8) 
2 (0) 
4 (.5) 
12 (6) 
4 (0) 
 
8 (57%) 
4 (29%) 
2 (14%) 
 
5 (36%) 
5 (36%) 
4 (28%) 
 
3 (23%) 
3 (23%) 
3 (23%) 
4 (31%) 
 
6 (46%) 
3 (23%) 
3 (23%) 
 
11 (42%) 
2 (8%) 
7 (27%) 
4 (15%) 
2 (8%) 
 
10 (71%) 
2 (14%) 
1 (7%) 
 
12 (86%) 
6 (43%) 
4 (29%) 
4 (29%) 
4 (29%) 
3 (21%) 
2 (14%) 
2 (14%) 
2 (14%) 
1 (7%) 
1 (7%) 
8 (62%) 
 
2 (17%) 
3 (25%) 
5 (42%) 
2 (17%) 
 
6 (43%) 
7 (50%) 
1(7%) 
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3.11 ART Monitoring 
Table 7-2 (see Appendices section) show that  all of the sites assessed reported providing adherence 
monitoring through both pill counts (86%) and self-reporting (86%). 86% of sites provided adherence 
counseling daily and adherence counseling job aids were also used in 86% of the sites. Providers 
conducted adherence assessments in the majority of sites visited (86%).Community Counselors 
provided background adherence counseling in almost all the sites visited (92%).93% of sites reported 
that adherence counseling was conducted by someone who had received adherence counseling 
training .However majority (55%) of those trained adherence counselors reported that they had last 
been trained more than 5 years ago.100% of sites reported documenting adherence counseling in 
either the patient care booklet (57%) or the patient passport (43%). Major reasons cited by patients 
for poor adherence included forgetting (79%); stigma (57%) and not having food (57%). 
Key challenges cited by sites in adherence counseling were; managing poor adherence in children 
(57%), managing patients with underlying factors for poor adherence (43%).Key support measures 
that would help provide better/ more effective adherence counseling was training (79%); more job 
aids (57%) and additional human resources (50%). 
3.12 Facility linkage to community care and support services  
Table 3-3 Facility Linkage to Community Care and Support Services 
Characteristic N (%) 
Refer clients for community support services (yes) Type of services clients are typically referred for 
                  OVC services (for children in care) 
Adherence support 
                  Disclosure 
                  Family testing 
Individual who routinely refers clients for community support services (4 were available for interview) 
                  Social worker 
                  Nurse 
                  Individual’s affiliation – government 
                  Individual is paid 
                                    Document referred clients for community support 
                                                      Document if patient received services referred for (Katutura Hospital, 5 adult 
patients were referred last quarter) 
Challenges with referring/ engaging patients for community services 
                  No community services available 
                  Limited community services available 
                  Community services have limited capacity to address patient needs 
                  Other 
What would help provide better/ more effective community linkages 
                  Wider range of community services available 
                  Additional resources for supporting community services 
                  Stronger relationship between facility and community providers/services 
   Other (training) 
7 (50%) 
 
5 (71%) 
4 (57%) 
3 (43%) 
2 (29%) 
 
 
3 (75%) 
1 (25%) 
4 (100%) 
3 (75%) 
1 (33%) 
1 (100%) 
 
 
 
2 (29%) 
5 (71%) 
2 (29%) 
3 (43%) 
 
4 (31%) 
2 (15%) 
6 (46%) 
1 (8%) 
Table 7-2 shows that few community groups remain active in the environment of the facilities 
assessed and many staff were not aware of available referral resources -limited availability of 
community services (71%) was cited as the major challenge for referring patients for 
community linkages. However 50% of sites reported referrals to community care and support 
services with the major types of services requested for the referrals were Orphans and 
Vulnerable Children (OVC) services (71%), Adherence support (57%) and disclosure (43%). 
  
 14 
 
3.13 Facility Staffing for ART care and support services  
Table 3-4 Facility Staffing at ART clinics (N=14) 
 TOTAL number of 
employees at all 
ART clinics 
Average 
among 14 
sites 
Minimum  Maximum 
Physician 21 1.5 0 6 
Pharmacist 27 1.9 0 8 
Registered Nurse 61 4.4 1 10 
Enrolled Nurse 33 2.4 0 4 
Lab technician 34 2.4 0 14 
Data clerk 33 2.4 0 5 
Community Health Worker/ Lay 
counselor 
52 3.7 1 10 
Social worker 4 0.3 0 2 
 
Table 3-4 illustrates that at least one clinic reported having zero physicians, pharmacists, 
enrolled nurse, lab technician, data clerk, and social worker. There are only 4 reported social 
workers across all 14 sites. Key staff at most facilities were registered nurses (average 4.4 per 
facility), lay counselors (average 3.7/facility) while there was minimal staffing in relation to 
doctors (1.5), pharmacists (1.9) and social workers (0.3). 
3.13.1 Physician/Patient Ratios 
Figure 3-9 (see also appendices: Table 7-3 Select Staffing type for ART clinic by Site) shows the 
Physician/patient ratio by site. 4 sites (Okalongo, Ongwediva Health Centre, Katima Mulilo 
and Nankudu) had no doctors assigned to the sites at the time of the assessment. Onandjokwe 
(1:9279), Outapi (1:6822), Engela (1:4889); Oshikuku (1: 4000) and Katutura Health Centre 
(1:3000) had the highest doctor/patient ratios while Khomasdal HC (1:448) and Katutura 
Hospital (1: 1122) had the lowest doctor/patient ratios at the time of the assessment. 
 
Figure 3-9 Doctor Patient Ratio by Health Facility 
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3.13.2 Registered Nurse/Patient Ratios 
Figure 3-10 Registered Nurse/Patient Ratio by Health Facility 
 
Figure 3-10 (see also appendices :Table 7-3 Select Staffing type for ART clinic by Site) shows that there 
were variations between facilities in patient load per registered nurse with Outapi Hospital (1:2100) 
and Onandjokwe (1:1800) also having the highest registered nurse patient ratios while Nankudu 
(1:448) and Ongwediva HC had the lowest ratios (1:200). 
 
3.13.3 Data Clerk/Patient Ratios 
Figure 3-11 Data Clerk/Patient Ratios by Health Facility 
 
Figure 3-11 shows that there were also variations in distributions of data clerks. Nankudu had 
no data clerk assigned to the facility and Okalongo Health Centre had the highest Data 
clerk/patient ratio (1:2800) while Khomasdal had the lowest (1:800). 
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3.13.4 Select staff training for ART clinics by staff type 
Table 3-5 Select Staff Training for ART Clinics by Staff Type 
   T
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Physician 21 17 (81%) 9 (43%) 7 (33%) 11 (52%) 10 (48%) 3 (14%) 
Pharmacist 27 7 (26%) 6 (22%) 2 (7%) 0 (0%) 7 (26%) 2 (7%) 
Registered Nurse 61 38 (62%) 20 (33%) 13 (21%) 27 (44%) 20 (33%) 8 (13%) 
Enrolled Nurse 33 7 (21%) 5 (15%) 6 (18%) 4 (12%) 2 (6%) 3 (9%) 
Lab technician 34 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Data clerk 33 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (9%) 19 (58%) 
Community Health 
Worker/ Lay counselor 52 2 (4%) 2 (4%) 33 (63%) 0 (0%) 0 (0%) 13 (25%) 
Social worker 4 1 (25%) 1 (25%) 1 (25%) 0 (0%) 0 (0%) 0 (0%) 
 
Table 3-5 shows that the majority (81%) of physicians were trained in adult ART followed by 
registered nurses (62%).Only 26% of pharmacists and 21% of enrolled nurses had been 
trained in adult ART. Less than 50% across all cadres had been trained in pediatric ART and 
ART pharmacy .63% of lay counselors were trained in adherence counseling but less than 35% 
across the cadres of doctors, nurses and pharmacist were trained in ART adherence 
counselling.58% of data clerks had been trained in ART data management but less than 15% 
of doctors, nurses and pharmacists reported having been trained in ART data management. 
3.13.5 Staffing duration of employment at ART sites 
Table 3-6 Staffing Duration of employment at ART sites 
  
TOTAL < 6 
months 
6 
months 
to < 1 
year 
1-2 
years 
2-5 years >5 years 
Physician 21 4 (19%) 7 (33%) 3 (14%) 4 (19%) 2 (10%) 
Pharmacist 27 5 (19%) 9 (33%) 0 (0%) 8 (30%) 0 (0%) 
Registered Nurse 61 12 (20%) 11 (18%) 1 (2%) 16 (26%) 22 (36%) 
Enrolled Nurse 33 8 (24%) 5 (15%) 7 (21%) 7 (21%) 6 (18%) 
Lab technician 34 3 (9%) 2 (6%) 3 (9%) 4 (12%)  22 (65%) 
Data clerk 33 0 (0%) 1 (3%) 4 (12%) 20 (61%) 8 (24%) 
Community Health 
Worker/ Lay counselor 52 0 (0%) 1 (2%) 2 (4%) 18 (35%) 31 (60%) 
Social worker 4 0 (0%) 1 (25%) 1 (25%) 0 (0%) 0 (0%) 
 
Table 3-6 shows that 52% of physicians and pharmacists had been employed in the sites for 
less than one year. In contrast more than 60% of registered and enrolled nurses had been at 
the sites for more than 1 year. Of the 33 data clerks in the sites assessed, 85% had been at 
the sites for between 2 -5 years.60% of lay counselors and 65% of laboratory technicians had 
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been at the site for more than 5 years while only 6 % of data clerks had been at the sites for 
periods of up to 2 years. 
 
3.14 Chart Review: Adults on ART between 1-2 years: Data 
validation and quality  
SOURCE: data from the patient booklet (N=118) and ePMS (N=118) for eight (8) sites was 
compared: Engela; Katima Mulilo; Katutura Health Centre; Katutura Int Hospital; Khomasdal 
Health Centre; Nankudu; Onandjokwe; and Rundu. 
Table 3-7 Chart Review: Adults on ART between 1-2 years (N=208): Data Validation and Quality 
Variable 
Patient booklet  
n (%)* 
ePMS 
n (%)* 
Female 70 (59%) 70 (59%) 
CD4 documented at ART initiation 113 (96%) 113 (96%) 
CD4 range (cells/mm3) 8 – 687 8 – 694 
CD4 median (cells/mm3) 243 231 
<100 15 (13%) 16 (14%) 
100-199 29 (26%) 30 (27%) 
200-349 58 (51%) 55 (49%) 
350-499 9 (8%) 10 (9%) 
>500 2 (2%) 2 (2%) 
Documentation   
Other indication for ART initiation (Yes) 47 (40%) 41 (35%) 
Hb or Hct at baseline (Yes) 100 (85%) 66 (57%) 
Creatinine clearance at baseline (Yes) 79 (68%) 16 (14%) 
ALT at baseline (Yes) 92 (79%) 61 (53%) 
HBsAg at baseline (Yes) 51 (64%) 30 (29%) 
If Yes, HBsAg result positive (Yes) 7 (14%) 2 (7%) 
HBsAg ever documented (Yes) 85 (86%) 52 (81%) 
If Yes, HBsAg result positive (Yes) 10 (12%) 3 (6%) 
CD4 and VL documentation 
Patient booklet 
n (%)* 
ePMS 
n (%)* 
CD4 documented within 15 months of ART initiation (Yes) 87 (74%) 74 (63%) 
CD4 range ( cells/mm3) 8 – 687 95 – 965 
CD4 median (cells/mm3) 243 406 
VL documented within 9 months of ART initiation (Yes) 85 (72%) 42 (36%) 
Less than 50 (including target not detected) 19 (22%) 8 (19%) 
Less than 400 30 (35%) 18 (43%) 
Less than 1000 (including target not detected) 62 (73%) 31 (73%) 
Greater than or equal to 1000 23 (27%) 11 (26%) 
Greater than or equal to 5000 7 (8%) 3 (7%) 
CD4 or VL documented (Yes) 102 (86%) 81 (69%) 
Documentation at last visit 
Review of side effects 105 (91%) 4 (3%) 
Adherence support** 114 (98%) 105 (90%) 
Receipt of cotrimoxazole 112 (98%) 90 (79%) 
Receipt of at least 3 prevention services*** 44 (37%) 1 (1%) 
TB screening 111 (95%) 98 (84%) 
TB screen result positive 3 (3%) 4 (4%) 
IPT prophylaxis (Y/N)**** 31 (32%) 16 (20%) 
IPT prophylaxis (NA)***** 10 (9%) 13 (14%) 
* N values differ due to missing data 
**Site has documentation of all three adherence support elements 
*** Site has documentation of delivery of, or referral to, at least three of the six HIV prevention messages and services (risk reduction counseling, condom 
provision, adherence counseling, partner HIV testing and counseling, STI diagnosis/treatment, contraception/ safer pregnancy counseling and provision) 
****Site has documentation that newly enrolled HIV patients who screen negative for active TB are given IPT 
*****Only four sites had documentation of IPT Prophylaxis not available (NA) due to current/ prior IPT or TB Rx, therefore this percentage may be an 
underrepresentation of the total percentage among all sites 
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Data from the patient booklet (N=118) and ePMS (N=118) for eight (8) sites was compared 
and shown in Table 3-7. No major differences between the ePMS and PCB were found in 
documented data on gender (59% female) and documentation of CD4 results at ART initiation 
in the patient booklet and ePMS (96%). 
Major differences in the documentation of other laboratory results were found between the 
patient booklet and EPMS. Overall the patient booklet showed greater documentation of the 
following lab results than found in the ePMS: Hb, AlT at baseline, creatinine clearance at 
baseline and HBsAg 
3.14.1 CD4 and VL documentation 
74% and 63% of patients reviewed had records showing CD4 documented within 15 months 
of ART initiation in the PCB and EPMS respectively. The documented CD4 ranges were 
significantly lower in the PCBs than in the EPMS [8-687 vs 95-965 respectively].Similarly the 
median CD4 recorded were significantly lower in the PCBs than EPMS the (406 vs 243 
respectively). 
72% and 36% of patients reviewed had records showing VL documented within 9 months of 
ART initiation in the PCB and EPMS. The proportions of patients with VL results classified 
within categories (i.e. <50, <400, <1000, ≥1000 and ≥ 5000) were however similar in both the 
PCB and EPMS 
3.14.2 Documentation at last visit 
98% and 79% had CTX documented in the PCB and ePMS respectively.37% and 1% had receipt 
of at least 3 prevention services documented in the PCB and ePMS respectively.95% and 84% 
had TB screening documented in the PCB and ePMS respectively.3% and 4% were 
documented as having screened positive in the PCB and ePMS respectively.32% and 20% were 
documented as being on IPT in the PCB and ePMS respectively. 
3.15 Chart review: Pediatric patients on ART at least 6 months: 
Data validation and quality  
SOURCE: site-level information from two data sources was analyzed. This includes the patient booklet 
(N=60) and ePMS (N=60) for six (6) sites: Engela; Katima Mulilo; Katutura Health Centre; Katutura Int 
Hospital; Onandjokwe; and Rundu. 
 
Table 3-8 shows similar data quality findings of data entered in EPMS and PCBs as follows: 
 60% female  
 Median age at ART initiation 5 years (see also figure 26 for age distribution) 
 97% of patients aged ≥5years had CD4 count at ART initiation  
 0% nutritional assessments used to categorize nutrition status 
However there were differences reflecting key data entry gaps in the ePMS in data captured 
for CTX given at last visit (93% in PCB vs 63% in ePMS) and TB screening at last visit (93% in 
PCB vs 78% in ePMS). 
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Table 3-8 Chart Review: Pediatric Patients on ART at least 6 months: Data Validation and Quality 
 
 
 
3.16 Chart Review: Adults on ART between 1-2 years: Patient care 
SOURCE: Source document* Data from all 14 sites (N=208) was utilized. The source document*  is 
patient booklet for eight (8) sites: Engela; Katima Mulilo; Katutura Health Centre; Katutura Int 
Hospital; Khomasdal Health Centre; Nankudu; Onandjokwe; and Rundu, and combined data from 
patient booklet and ePMS (composite) for six (6) sites: Okalongo Health Centre; Ongwediva Health 
Centre; Oshakati; Oshikuku; Outapi; and Tsandi. Data collection in these six sites was conducted in such 
a way that a distinction could not be made for the data source (ePMS versus patient booklet). The 
source document was chosen to give the most accurate clinical data for each patient. 
 
CD4 documented and other lab result at ART initiation 
Table 3-9   shows that 98% had CD4 documented at ART initiation and the median CD4 within 15 
months of ART initiation was 246 cells/mm3.85%, 74% and 83% had baseline Hb, creatinine clearance 
and ALT results respectively. Of the 76% with HBsAg result ever documented, about 11% had a 
positive result. Figure 3-12 illustrates that while the majority of patients (53%) initiated ART 
with CD4 counts in the 200-350 range; about 37% of patients initiated ART with CD4 less than 
200. 
 
CD4 and VL documentation 
73% had CD4 documented within 15 months of ART initiation while 69% had VL documented within 9 
months of ART initiation. 95% had an initial VL result documented at any point and 75% had an initial 
VL result less than 1000 within 9 months (including target not detected). 
 
 
 
 
 
 
 
Variable Patient booklet    
N (%) 
ePMS                      N (%) 
Female 36 (60%) 36 (60%) 
Age at ART initiation   
Range 0.2 – 12.4 years 0.2 – 12.3 years 
Median 4.5 years 5.0 years 
Under 2 years 15 (25%) 14 (23%) 
2 to <5 years 16 (27%) 15 (25%) 
5 to <10 years 
10 to <15 years 
23 (38%) 
6 (10%) 
25 (42%) 
6 (10%) 
CD4 count at ART initiation (age ≥5 yrs) 28 (97%) 28 (90%) 
Documentation at last clinical assessment: Patient booklet    
N (%) 
ePMS                      N (%) 
Cotrimoxazole given at last visit 56 (93%) 37 (63%) 
Appropriate growth monitoring at last visit  17 (34%) 14 (28%) 
Nutrition assessment used to categorize nutrition status 1 (2%) 0 (0%) 
TB screening at last visit 57 (93%) 47 (78%) 
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Table 3-9 Chart Review: Adults on ART between 1-2 years (N=208): Patient Care 
Variable Source document* n (%) 
Female 133 (64%) 
CD4 documented at ART initiation 203 (98%) 
CD4 range (cells/mm3) 8 – 687 
CD4 median (cells/mm3) 246 
<100 26 (13%) 
100-199 48 (24%) 
200-349 108 (53%) 
350-499 17 (8%) 
>500 4 (2%) 
Other indication for ART initiation (Yes) 72 (35%) 
Hb or Hct at baseline (Yes) 176 (85%) 
Creatinine clearance at baseline (Yes) 154 (74%) 
ALT at baseline (Yes) 170 (83%) 
HBsAg at baseline (Yes) 114 (67%) 
If Yes, HBsAg result positive 12 (11%) 
HBsAg ever documented (Yes) 129 (76%) 
If Yes, HBsAg result positive 10 (11%) 
CD4 and VL documentation  
CD4 documented within 15 months of ART initiation (Yes) 152 (73%) 
CD4 range ( cells/mm3) 8 – 687 
CD4 median (cells/mm3) 246 
VL documented within 9 months of ART initiation (Yes) 144 (69%) 
Less than 50 (including target not detected) 36 (25%) 
Less than 400 (including target not detected) 83 (58%) 
Less than 1000 (including target not detected) 108 (75%) 
Follow up VL 14 (13%) 
Greater than or equal to 1000 36 (25%) 
Follow up VL 7 (19%) 
Greater than or equal to 5000 7 (5%) 
CD4 or VL documented at baseline (Yes) 175 (84%) 
Viral load (not time sensitive)  
Initial VL (not time sensitive) 
Less than 50 (including target not detected) 
Less than 400 (including target not detected) 
Less than 1000 (including target not detected) 
Greater than or equal to 1000 
Greater than or equal to 5000 
198 (95%) 
60 (30%) 
124 (63%) 
152 (77%) 
46 (23%) 
12 (6%) 
2nd VL (not time sensitive) 
Less than 50 (including target not detected) 
Less than 400 (including target not detected) 
Less than 1000 (including target not detected) 
Greater than or equal to 1000 
Greater than or equal to 5000 
143 (69%) 
84 (59%) 
110 (77%) 
123 (86%) 
20 (14%) 
10 (7%) 
 
3rd VL (not time sensitive) 
Less than 50 (including target not detected) 
Less than 400 (including target not detected) 
Less than 1000 (including target not detected) 
Greater than or equal to 1000 
32 (15%) 
22 (69%) 
28 (88%) 
29 (91%) 
3 (9%) 
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Variable Source document* n (%) 
Greater than or equal to 5000 0 (0%) 
4th VL (not time sensitive) 
Less than 50 (including target not detected) 
Less than 400 (including target not detected) 
Less than 1000 (including target not detected) 
Greater than or equal to 1000 
Greater than or equal to 5000 
3 (1%) 
2 (67%) 
2 (67%) 
2 (67%) 
1 (33%) 
1 (33%) 
Last VL was conducted within the past year+ 
Less than 50 (including target not detected) 
Less than 400 (including target not detected) 
Less than 1000 (including target not detected) 
Greater than or equal to 1000 
Greater than or equal to 5000 
122 (59%) 
94 (77%) 
109 (89%) 
115 (94%) 
7 (6%) 
4 (3%) 
Documentation  
Review of side effects (Yes) 195 (95%) 
Adherence support (Yes)** 204 (99%) 
Receipt of cotrimoxazole (Yes) 198 (99%) 
Receipt of at least 3 prevention services (Yes)*** 63 (30%) 
TB screening (Yes) 200 (97%) 
If Yes, TB screen result positive 5 (2%) 
IPT prophylaxis (Y/N)**** 81 (45%) 
IPT prophylaxis (NA)***** 14 (8%) 
* N values differ due to missing data 
**Site has documentation of all three adherence support elements 
*** Site has documentation of delivery of, or referral to, at least three of the six HIV prevention messages and 
services (risk reduction counseling, condom provision, adherence counseling, partner HIV testing and counseling, STI 
diagnosis/treatment, contraception/ safer pregnancy counseling and provision) 
****Site has documentation that newly enrolled HIV patients who screen negative for active TB are given IPT 
*****Only four sites had documentation of IPT Prophylaxis not available (NA) due to current/ prior IPT or TB Rx, 
therefore this percentage may be an underrepresentation of the total percentage among all sites 
+ Viral load was conducted and documented between December 1, 2013 and November 30, 2014. 
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3.17 Adult patient CD4 count (cells/mm3) at ART initiation 
 
 
 
Error! Reference source not found. Shows that at ART initiation the majority (90%) of patients had a 
CD4 of less than 350 with the largest proportion (53%) of these in the 200-349 category. Only 10% of 
Adult patients were initiated on ART with a CD4> 350. 
3.18 Chart Review: Pediatric Patients on ART between 1-2 years: 
Patient care 
 
Error! Reference source not found. below shows that similar to adults, the majority (96%) of 
pediatric patients had a CD4 at ART initiation.79% had a viral load performed within the last 
year of the site visit and 62% had VL less than 1000 (including target not detected).Also similar 
to adult care, 96% had CTX given and TB screening conducted at the last visit .While 51% had 
appropriate growth monitoring at the last visit, only 8% had nutritional assessment used to 
categorize nutrition status. 
 
 
 
 
 
 
 
13%
24%
53%
8%
2%
0%
10%
20%
30%
40%
50%
60%
<100 100-199 200-349 350-499 ≥500
Adult patient CD4 count at ART initiation (n=203)
Figure 3-12 Adult Patient CD4 count (cells/mm3) at ART initiation (N=203) 
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Table 3-10 Chart Review of Pediatric Patients at Least 6 months (N=116) Patient Care 
Female 65 (56%) 
Age at ART initiation 
Range 
Median 
Under 2 years 
2 to <5 years 
5 to <10 years 
10 to <15 years 
 
0.2 – 12.4 years 
4.8 years 
32 (28%) 
28 (24%) 
42 (36%) 
14 (12%) 
CD4 count at ART initiation (age ≥5 yrs) 54 (96%) 
Last VL was conducted within the past year from site visit+  
Less than 400 (including target not detected) 
Less than 1000 (including target not detected) 
Greater than or equal to 1000 
Greater than or equal to 5000 
92 (79%) 
61 (68%*) 
62 (69%*) 
28 (31%*) 
18 (20%*) 
Documentation at last clinical assessment: Source document             N (%) 
Cotrimoxazole given at last visit 110 (96%) 
Appropriate growth monitoring at last visit  54 (51%) 
Nutrition assessment used to categorize nutrition status 8 (8%) 
TB screening at last visit 112 (96%) 
SOURCE: Source document* site-level data from the source document was used for 13 sites (N=116). The source 
document* is patient booklet for seven (7) sites: Engela; Katima Mulilo; Katutura Health Centre; Katutura Int 
Hospital; Onandjokwe; Nankudu; and Rundu; and combined data from patient booklet and ePMS for six (6) sites: 
Okalongo Health Centre; Ongwediva Health Centre; Oshakati; Oshikuku; Outapi; and Tsandi. Data collection in 
these 6 sites was conducted in such a way that a distinction could not be made for the data source (ePMS versus 
patient booklet). The source document was used to give the most accurate clinical data for each patient. 
+ Viral load was conducted and documented between December 1, 2013 and November 30, 2014. 
* Denominator = 90 (number of patients with VL value) as Oshakati has two VL dates without VL values 
documented 
 
3.19 First VL Value Of Adult ART Patients by Site and Region  
Table 3-11 below shows that 69% (144) of the 208 adults initiated on ART in the assessed 
facilities received viral load measurement within 9 months of treatment initiation.  While the 
highest rate of VL measurement (80-100%) were seen in Ohangwena, Khomas and Oshana 
regions, the lowest rates (20-50%) were seen in Zambezi, Kavango and Omusati regions. 75% 
(108) of those who received viral load measurement achieved suppression (<1000 copies/ml 
of blood).  Highest (92-100%) VL suppression was seen in Kavango and Oshana regions and 
lowest (<50%) in Zambezi and Ohangwena regions. 
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Table 3-11 First VL Value (% within 9 months of ART by Site and Region (N=208) initiation) of Adult ART Patients 
Region Total  
(n %) 
VL < 1000 
n (%) 
VL > 1000 
n (%) 
Site (N=15) Total  
(n %) 
VL < 1000 n 
(%) 
VL > 1000 
n (%) 
Ohangwena 
(N=15) 
15 (100%) 7 (47%) 8 (53%) Engela 15 (100%) 7 (47%) 8 (53%) 
Zambezi 
(N=15) 
3 (20%) 1 (33%) 2 (67%) Katima Mulilo 3 (20%) 1 (33%) 2 (67%) 
Khomas 
(N=45) 
40 (89%) 33 (83%) 7 (18%) Katutura HC 14 (93%) 12 (86%) 2 (14%) 
Katutura Hospital 12 (80%) 10 (83%) 2 (17%) 
Khomasdal HC 14 (93%) 11 (79%) 3 (21%) 
Kavango 
(n=14) 
10 (71%) 7 (70%) 3 (30%) Nankudu (N=14) 10 (71%) 7 (70%) 3 (30%) 
Omusati 
(n=30) 
20 (67%) 14 (70%) 6 (30%) Okalongo HC 10 (67%) 5 (50%) 5 (50%) 
Tsandi 10 (67%) 9 (90%) 1 (10%) 
Oshikoto 
(n=15) 
11 (73%) 8 (73%) 3 (27%) Onandjokwe 11 (73%) 8 (73%) 3 (27%) 
Oshana 
(n=30) 
24 (80%) 22 (92%) 2 (17%) Ongwediva HC 12 (80%) 10 (83%) 2 (17%) 
Oshakati 12 (80%) 12 (100%) 0 (0%) 
Omusati 
(n=30) 
15 (50%) 10 (67%) 5 (33%) Oshikuku 6 (40%) 3 (50%) 3 (50%) 
Outapi 9 (60%) 7 (78%) 2 (22%) 
Kavango 
(n=14) 
6 (43%) 6 (100%) 0 (0%) Rundu (N=14) 6 (43%) 6 (100%) 0 (0%) 
TOTAL 144 (69%) 108 (75%) 36 (25%) TOTAL 144 (69%) 108 (75%) 36 (25%) 
 
 
 
 
3.20  Last VL Value of Adult ART Patients by Site and Region  
 
NOTE: The following tables (Tables 3-11 to 3-12) look at VL data collected for each patient. “Initial 
VL” is defined as the patient’s first VL (regardless of when it occurred), “Last VL” or “f/u VL” is defined 
as the patient’s most recent VL (regardless of when it occurred).  
Table 3-12 shows that 115 (94%) of the 122 adult patients with a last viral load conducted 
between Dec 1 2013 and November 30 2014 had viral load suppression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
Table 3-12 Last VL Value (% between Dec1 2013 and Nov 30 2014) of Adult ART Patients by Site and region 
 
Region Total  
(n %) 
VL < 1000 
n (%) 
VL > 1000 
n (%) 
Site Total  
(n %) 
VL < 1000 
n (%) 
VL > 1000 
n (%) 
Ohangwena 
(N=15) 
8 (53%) 6 (75%) 2 (25%) Engela 8 (53%) 6 (75%) 2 (25%) 
Zambezi 
(N=15) 
5 (33%) 5 (100%) 0 (0%) Katima Mulilo 5 (33%) 5 (100%) 0 (0%) 
Khomas 
(N=45) 
27 (60%) 27 (100%) 0 (0%) Katutura HC 11 (73%) 11 (100%) 0 (0%) 
Katutura 
Hospital 
5 (33%) 5 (100%) 0 (0%) 
Khomasdal HC 11 (73%) 11 (100%) 0 (0%) 
Kavango 
(n=14) 
6 (43%) 6 (100%) 0 (0%) Nankudu 
(N=14) 
6 (43%) 6 (100%) 0 (0%) 
Omusati 
(n=30) 
20 (67%) 18 (90%) 2 (10%) Okalongo HC 9 (60%) 8 (89%) 1 (11%) 
Tsandi 11 (73%) 10 (91%) 1 (9%) 
Oshikoto 
(n=15) 
6 (40%) 6 (100%) 0 (0%) Onandjokwe 6 (40%) 6 (100%) 0 (0%) 
Oshana 
(n=30) 
24 (80%) 24 (100%) 0 (0%) Ongwediva HC 12 (80%) 12 (100%) 0 (0%) 
Oshakati 12 (80%) 12 (100%) 0 (0%) 
Omusati 
(n=30) 
15 (50%) 14 (93%) 1 (7%) Oshikuku 5 (33%) 4 (80%) 1 (20%) 
Outapi 10 (67%) 10 (100%) 0 (0%) 
Kavango 
(n=14) 
11 (73%) 9 (82%) 2 (18%) Rundu (N=14) 11 (73%) 9 (82%) 2 (18%) 
TOTAL 122 (59%) 115 (94%) 7 (6%) TOTAL 122 (59%) 115 (94%) 7 (6%) 
 
 
 
3.21 Last VL Value of Pediatric ART Patients by Site and Region 
 
Table 7-4  in the appendices section shows that of the total 116 pediatric (0-14 years) patient 
charts reviewed, 92 (79%) had viral load measurement done within 8-12 months after ART 
initiation. 69% (62 out of 90) of those children who had VL measurement at 8-12 months after 
ART initiation also showed suppression (<1000 copies/ml of blood).  The highest suppression 
rate was seen in Khomas region (83%) and the lowest was in Kavango region (0%). 
 
3.22 : Characteristics of Adult ART Patients Viral Load  
Table 7-5 in the appendices shows that 76.8% (152) of the 198 adults who had VL measurement 
(within 8-12 months) showed suppression (<1000 copies/ml of blood).74% (34) of the 42 who failed 
to suppress their viral load during the first VL measurement had second round VL measurement which 
according to the ART guideline was expected to be done within 3 months.  Accordingly, 28 (76.5%) of 
them showed suppression (<1000 copies/ml of blood). 
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4 DISCUSSION 
 
 
4.1 Care and Treatment: Adult, Adolescent and Pediatric 
 
The assessment showed that among the 15 sites which were surveyed, few sites keep a daily record 
of scheduled patients. There was no system of tracking or following up after a patient misses an 
appointment (i.e. No system for ePMS/EDT missed appointments→ Social worker/community 
counselor/adherence nurse→ phone system/community-based patient tracking).Given the absence of 
such a system, there was therefore limited documentation of outcomes of efforts to track and return 
patients to care. In view of the heightened goals of retaining patients in care and achieving the viral 
load suppression goals of the 90:90:90 approach, it is vital for facilities to establish systems that would 
enable them to rapidly identify patients who miss their follow ups, be able to track them using 
established patient tracking mechanisms and finally be able to determine the outcomes of lost to 
follow up tracking efforts. 
Similar to the 2014 MOHSS EWI report, the assessment also identified that ARV supply chain 
interruptions were experienced as a result of rupture of the system at the national level. This probably 
provides the greatest risk of treatment interruption among patients on ART and may lead to 
emergence of HIV DR. 
 
Retention in care is influenced by level of staff training, proximity of ART services to where clients live 
and limited patient waiting time at the clinic. The three most common suggestions made by health 
workers on ways to improve patient retention in care were reducing waiting time in clinics, 
strengthening staff training and expansion of ART services to where they are needed most. Strategies 
to implement these interventions will need to be supported by the MOHSS and partners. 
 
With regards to pediatric care and treatment; the most worrying finding was that routine Provider 
Initiated Testing and Counseling (PITC) was not performed or documented for inpatients. Given the 
likelihood of high positivity rates among admitted pediatric patients, and the high HIV-associated 
morbidity and mortality among these age groups, it is critical that steps should be taken to strengthen 
the implementation of pediatric testing through PITC. 
 
On M&E for pediatric care and treatment, the assessment noted that there was poor documentation 
of children’s heights, BMI and nutritional assessment partly due to the old design of patient care 
booklets. However the new patient charts and ePMS is expected to improve documentation practices. 
 
Lastly it was generally noted that there was poor communication and weak linkages between 
community groups and health care facilities. 
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4.2 Food and Nutrition/Pediatric growth monitoring 
Completing an anthropometric assessment at each clinic visit and documenting results is an essential 
element in comprehensive HIV care and treatment as growth faltering can be the first sign of ART 
failure or other undiagnosed illnesses among children living with HIV. The Namibian Nutritional 
Guideline also recommends that all HIV infected children attending the ART clinic should undergo 
anthropometric assessment to categorize their nutritional status. The assessment showed that 77% 
of the sites did not have documentation of anthropometric assessment (i.e. weight and length or 
height, BMI, MUAC, or growth monitoring curve) during the last clinical visit per national guideline 
(Section 3.4).As part of the broader efforts to improve data quality and completeness, program 
managers and health providers should improve efforts to ensure improvement in this area of pediatric 
clinical care. 
 
4.3 Adult and Pediatric care and support  
Key findings of the assessment in this domain were that few community groups remain active and in 
cases in which such services were available, staff not aware of the available resources.Furthermore 
the assessment identified that there was generally poor communication and weak linkages between 
community groups and health care facilities. Attaining the 90:90:90 goals is dependent on close 
cooperation between health facilities and community-based services. This is therefore and area which 
will require additional strengthening. Operationalizing activities spelt out in Objective 7.3.6 of the 
MOHSS Treatment Operational Plan will go a long way in addressing these challenges. The main 
activities proposed under that objective include: 
 Create an enabling environment for meaningful participation of PLHIV in comprehensive HIV 
and AIDS care, including ART 
 Recruit, motivate and retain community health workers 
 Develop appropriate IEC materials to support HIV care and treatment programme targeting 
different population groups including the disabled persons 
 Build the capacity of non-health personnel to support ART delivery 
 Provide community home -based care services including bi-directional referral 
4.4 Laboratory 
 
Most facilities (50-86%) provide basic TB/HIV related lab services on site. At the time of the assessment 
VL is done at central NIP lab in Windhoek for all sites except for 2 sites. Almost all TB/HIV lab services 
were provided at all clinic hours.TB/HIV testing interruptions were reportedly common and were 
strongly linked to supply shortage, equipment failure, staff shortage, and stock out/expiry of testing 
kits. 
Although Meditech database allows efficient specimen management, processing and reporting of 
results, there was lack of strong data linkage with the national ART management system (the ePMS) 
causing frequent loss of lab results and/or delayed acquisition by the care provider in order to manage 
patients based on the results 
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4.5 Medication management 
It was encouraging to note that the current medication management system was adequately 
documented, reviewed and updated in order to minimize problems of drug stock-out and need for 
frequent emergency supply requests. 
4.6 TB/ HIV 
According to the National TB/HIV guideline, all sites should have a protocol for performing and 
documenting screening for active tuberculosis (TB) at each clinical visit for all HIV-infected patients.  
There is still an important gap to fill in this regard as about 20% of the sites lacked a combination of 
essential resources (SOPs and screening algorithms) and failed to provide TB screening services to all 
eligible patients. All HIV-positive patients who screen negative for active TB should receive IPT per 
national guidelines. 
4.7 Site performance management (ART) and QM/QI system 
There were major challenges in supervisory support visit provided to ART sites which can negatively 
influence quality of service delivery and staff motivation.In general sites reported poor supportive 
supervision with written feedback to most facilities. In addition there was poor HIV QM/QI systems at 
most facilities visited as well as poor assessment and utilization of site level data by facility teams for 
program improvement. 
4.8 ART Monitoring 
 
While all sites reported that adherence counseling was provided by a trained counselor, the majority 
of providers were last trained more than 5 years ago. Providers requested more training, job aids and 
additional staff to enable sites to improve the quality of adherence counseling. 
Forgetting to take medicines was cited as the leading cause of poor adherence. Interventions such as 
SMS reminders can help ameliorate this challenge and improve adherence to treatment. 
There was very good indication that ART sites are initiating patients in conformity with the national 
ART guideline and fewer percentage of patients had very low CD4 count at ART initiation 
 
4.9 Patient Tracking 
The assessment revealed that facility stock outs were largely driven by National level outages (Linked 
to the results of ARV and CTX outages in figures 1, 2 and 5). 
Facilities reported that patients often gave old outdated contact details during registration and often 
these phone numbers or addresses were not reachable once facilities were attempting to track lost 
patients. There is therefore a need to improve collection and regular updating of correct patient 
contact information to enable easy follow up when patients fail to come for follow up. Providers who 
were interviewed cited transportation as a major reason for patients missing their appointments; 
further highlighting the need to decentralize services to as close to where patients stay as possible. 
 
4.10 Facility linkage to community care and support services  
As highlighted before in this report in Section 4.3, there were challenges with limited availability of 
community services and many sites are not actively referring patients for services outside the facilities 
due to this limitation. Operationalizing activities spelt out in Objective 7.3.6 of the MOHSS Treatment 
Operational Plan will go a long way in addressing some of these challenges. 
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4.11 Facility Staffing for ART care and support services 
Assessment of staffing at the various clinics revealed that nurses and lay counselors are the major staff 
in ART facilities. There was a notable absence of social workers noted in many facilities. 
 
There were also notable disparities’ in distribution of available staff resources between sites noted 
(doctors, registered nurses and data clerks) for ART services. For instance; one doctor in Onandjokwe 
oversees 4 times his counterpart in Oshakati and more than 18 times the number of patients overseen 
by a counterpart in Khomasdal Health Centre. Similarly a registered nurse in Outapi is responsible for 
almost 10 times more patients than a counterpart in Ongwediva Health Centre. 
 
With respect to data clerks, the disparities are not as marked as for clinical staff with the majority of 
sites showing that each data clerk manages about 1500-2000 patient. However a data clerk in 
Okalongo is responsible for managing 2800 patient files which is about 3.5 times that of a counterpart 
in Khomasdal HC. 
 
Most registered nurses and doctors were trained in adult ART but major gaps in training exist among 
pharmacists and enrolled nurses. However major gaps exist in pediatric ART training across all types 
of cadres. 
 
While a significant proportion of lay counselors reported being trained in adherence counselling-the 
majority of all other cadres had not received formal training in ART adherence counselling. 
  
With regards to data management, about two thirds of data clerks had formally been trained but a 
tiny proportion (less than 15%) of all other clinical staff had received formal training on that topic. 
Given that nurses are taking more and more of data entry through NIMART expansion, it will be 
important to target greater numbers of clinical staff in data management trainings. 
 
Data suggests rapid turnover of physicians and pharmacists in the ART sites with only about 30% of 
these cadres having served in the sites for more than 2 years. This is likely linked to the general 
shortage of these cadres across the hospital services such that many are rotated from ART services to 
other divisions. 
 
Registered nurses provide some continuity in the sites with about 52% reporting having been at the 
sites for more than 2 years .Data clerks, lab technicians and lay counselors had the least turnover with 
majority having served the sites for 2-5 years or more.  
 
This data showing rapid turnover of physicians and pharmacists from ART sites but more stability 
among nurses and other cadres further supports the GRN strategy of scaling up NIMART which aims 
to build the capacity of registered nurses to initiate and manage ART patients. 
 
4.12 Chart Review: Adults on ART between 1-2 years and Pediatric 
Patients at least 6 months: Data validation and quality Chart 
The biggest concern with findings on data quality and validation was that overall the ePMS showed 
significantly incomplete documentation of lab results compared to data available within the PCBs. The 
greatest disparity in documenting lab results was with VL results. Only half of the patients who had a 
VL result recorded in the PCB, had the result also captured in the ePMS (72% vs 36% receptively). This 
potentially has significant implications in our capacity to accurately monitor programmatic VL 
outcomes (the last 90 in the 90:90:90) using ePMS data. 
 30 
 
4.13 Review: Adults and Pediatric on ART between 1-2 years: 
Patient care 
Comparisons showed that PCB and ePMS data variables were similar at initiation. However follow up 
data variables more complete in PCB than in ePMS with up to 30% incomplete data in the ePMS 
compared to the PCB. 
As described earlier pediatric nutritional assessments to categorize nutritional status were not 
routinely done.There were gaps in VL testing with <80% of patients receiving VL testing within the 
recommended periods per the national guidelines. Furthermore there were major gaps in viral load 
suppression rates (<70%) among pediatrics indicating additional efforts are required to reach the 90% 
suppression rates targeted per the 90:90:90 approach. 
On a more positive note, the assessment revealed high rates of CTX prophylaxis and TB screening. 
 
4.14 Viral Load Results  
Although the VL measurements rate (69%) observed through adult patient chart review were not very 
low, similar data extracted from ePMS revealed that only 37% of the eligible patients received this 
service; pointing towards major gaps in data quality. Three-fourth (75%) of adult patients who 
received VL measurement within 6-9 months of ART initiation achieved suppression, which is not very 
high given the target of reaching 90% suppression rates. 
The 15 sites assessed showed wide range of variation in average VL suppression rates which entails 
differences in the level of quality of care and/or treatment adherence.   
The difference in the rate of VL measurement at 9 months (69%) and 8 to 12 months after ART 
initiation (76.8%) points towards potential challenges in longer laboratory turn-around time or delays 
in documentation of results. The high levels of viral suppression after second VL measurement 
indicates that adherence is an important challenge in ART programs and once adherence is provided, 
the majority of patients are able to reach VL suppression. 
More worryingly, the VL measurement and suppression rates for pediatric patients are significantly 
lower than for adults.  This phenomenon points to serious gap in pediatric ART outcomes and possibly 
the quality of ART care among children.   As in the case with adult patients, there was significant 
difference in the rate of VL measurements at 9 months (50%) and 8 to 12 months after ART initiation 
(79%) indicating same problems relating to either delayed performance of viral load tests by providers; 
longer laboratory turn-around time or delays in documentation of results. This will require ongoing 
further investigation by providers and mentors at individual facility level in order to come up with 
strategies for improving VL testing rates. 
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5 RECOMMENDATIONS  
5.1 Care and Treatment: Adult, Adolescent and Pediatric 
1 Strengthen and expand ongoing activities to track Lost To Follow Up (LTFU) patients  
2 Improve patient flow organizations in ART clinics to reduce waiting times 
3 Develop and implement systems (SOPs)  to track and document outcomes for patients who 
miss scheduled visits using data (ePMS or EDT queries) 
4 Improve National level Adult ARV supply chain reliability 
5 Need for innovative interventions to scale up the implementation of PITC especially in children 
6 Improve pediatric growth monitoring and recording of such in the patient records 
7 Urgent need to support systems for facility pediatric patient linkage to community care and 
support 
5.2 Adult and Pediatric care and support (Including Pediatric Food 
and Nutrition) 
1 Urgent need to support systems for facility Adult patient linkage to community care and 
support 
2 Support and sustain community services with strong linkages to health care facilities to 
promote adherence and retention in care 
3 Monitor implementation of the MoHSS bi-directional referral system and documentation 
tools 
4 Improve the implementation of facility-based PHDP 
5 Provide training, necessary equipment/supplies and supportive supervision in order to 
implement the national guideline for routine growth monitoring for children living with HIV 
during each clinical visit.   
5.3 Laboratory 
1. Improve linkage and interface of the Meditech database with ePMS to ensure accurate and 
timely acquisition of essential laboratory test results for HIV diagnosis, care and treatment. 
2. Sites need to plan to minimize and/or manage emergency situations related to TB/HIV testing 
interruptions 
3. Essential TB/HIV lab services (CD4 test, blood chemistry, sputum microscopy, GenXpert) must be 
made available at main ART sites  
4. There is a strong need to decentralize VL testing at least to the main ART sites 
5.4 TB/ HIV 
1. Improve TB screening activities through health worker training and mentoring 
2. There is a need to clarify national guideline for patients who have already been given the 6-9 
months INH prophylaxis  
3. More healthcare worker training and awareness raising on the benefit of IPT and IPT 
guidelines 
5.5 Site performance management (ART) and QM/QI system 
1. The critical benefit of regular site-level supportive supervision must be acknowledged in ART 
service and necessary logistic and financial commitment must be made to implement it 
accordingly 
2. Implement more regular site supportive supervision with written feedback 
3. Strengthen support for QI/QM systems at facility level through clinical mentors, QI focal 
persons and coaches 
4. Build site level capacity to improve data analysis and utilization for facility service 
improvement 
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5.6 Patient Tracking 
1. Improve National level adult ARV supply chain reliability to prevent ART stock outs reported 
at site level. 
2. Develop and implement systems (including SOPs) and system to track and document 
outcomes for patients who miss scheduled visits using data (ePMS or EDT queries) including 
collaboration with Community-based organizations 
3. Develop and implement innovative strategies to lessen the burden of transportation on 
patients coming for regular clinical reviews and/or pill pick up e.g. Provide medicines for 
more than one month scripts for stable patients and consider other proven interventions 
such as Community-based ART distribution 
5.7 ART Monitoring 
1. While all sites reported that adherence counseling was provided by a trained counselor, the 
majority of providers were last trained more than 5 years ago. The recommendation is to 
provide refresher adherence trainings to key clinical staff who have not received updated 
adherence information. 
2. Provide more training, job aids and additional staff to enable sites to improve the quality of 
adherence counseling. 
3. Implement interventions such as SMS reminders can help improve adherence and retention 
to treatment. 
5.8  Facility linkage to community care and support services  
1. Conduct local mapping of currently available community services and avail the information 
to health facilities. This information can be used in implementing the bi-directional referral 
system 
2. Create synergies between CBOs and the expanded Community Health Extension Worker 
Program to improve coverage of community services 
5.9  Facility Staffing for ART care and support services 
1. Considering that nurses and lay counselors are the bedrock of services in ART clinics-they 
should be the primary target for capacity building to ensure quality service provision. 
2. Address the general shortage of social workers in most health facilities. 
3. In view of general staff shortages for ART services there is need for equity (taking into account 
the patient load, level of facility and unique considerations of the geographic location of the 
site) in future staff resource distribution across the different types of staff cadres. 
4. Given the limited opportunities for training, when national and regional teams are planning 
trainings-priority should be given to: 
 Topics that have low coverage among key staff 
 Cadres already working in ART services who are not yet trained in particular topics 
when local managers are selecting participants to nominate for training workshops 
5. Clinical and nurse mentors should use the data on training gaps to identify topics for onsite 
mentoring and training. Other platforms such as Digital Video Conferencing (DVC) and ECHO 
should consider the data on training gaps to identify topics that can be covered through these 
training platforms 
6. NIP to organize trainings to update Laboratory scientists on ART laboratory monitoring 
guidelines 
7. When rotating staff-there has to be a purposeful plan to ensure that at any given time-there 
is always someone with experience in ART management. Ensure bridging during transitions 
and avoid situations where the clinic is manned by completely new staff when all experienced 
staff have been rotated out of the ART clinic. 
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5.10 Chart Review: Data validation and quality Chart 
1. Overall-there is need to improve the completeness of the documentation of lab results in the 
ePMS 
2. Given that VL results are now the pivotal lab result for monitoring both clinical and 
programmatic performance –there is need to: 
a. Ensure that these VL results data are completely documented and validated in both 
the PCBs and the ePMS. 
b. Strengthen strategies to enhance data completeness in the ePMS during  patient 
follow up visits 
c. Provide mentorship to sites and implement QI  to improve site performance in 
utilizing pediatric nutritional assessments for categorizing pediatric  nutritional status 
5.11 Viral Load Monitoring and Outcomes 
1. Improve routine site-level ePMS data validation and auditing procedures 
2. Conduct regular site-level performance assessment/analysis in order to identify specific 
problems hindering achievement of high rate of VL measurement and suppressions  
3. Need for experience sharing among ART sites to disseminate best practices  
4. Improve compliance with ART guideline regarding regular VL measurement 
5. Reduce lab turn-around time through decentralization of VL measurement services 
6. Improve adherence counseling services 
7. Pediatric ART care needs to be the next priority activity in ARV program 
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6 LIMITATIONS  
 
The SQA report shares very informative findings from the sites that participated in the assessment. However the key 
limitations are that SQA was conducted in only 14 sites so may not be representative of all major ART sites in the 
country. Furthermore the site selection did not include smaller, IMAI or outreach sites .There was also limited VL data 
at site level to make conclusive remarks especially with 3rd VL tests and outcomes.
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7 APPENDICES  
Table 7-1: Aggregate results of service assessment scorecard (N=14 sites) 
 
 
 
Domain Element 
Needs urgent 
remediation  
Needs 
improvement 
Meets 
standard 
Exceeds 
standard 
Adult/Adolescent care and 
treatment 
Patient tracking 50% 36% 0% 14% 
Adherence support 0% 0% 50% 50% 
ART monitoring adult 7% 0% 29% 64% 
 Supply chain reliability (ARVs) 43% 7% 29% 21% 
Reference materials 7% 0% 14% 79% 
Adult care and support 
Cotrimoxazole 0% 0% 0% 100% 
Facility linkage to community 
care and support 
100% 0% 0% 0% 
Supply Chain Reliability (CTX) 7% 0% 0% 93% 
PHDP 57% 7% 21% 14% 
Food and nutrition 
Pediatric growth monitoring 
(N=13) 
77% 23% 0% 0% 
Laboratory 
Testing interruptions (N=12) 17% 33% 8% 42% 
Results and information 
management (N=12) 
0% 8% 25% 67% 
Medication management 
Supply chain management 
(N=13) 
0% 0% 31% 69% 
Medication dispensing 7% 7% 57% 29% 
Pediatric care and treatment 
Pediatric ART eligibility 0% 7% 36% 57% 
Pediatric ART monitoring 0% 14% 21% 64% 
Supply chain reliability 
(pediatric ARVs) 
29% 14% 7% 50% 
Supply chain reliability 
(pediatric cotrimoxazole) 
7% 0% 0% 93% 
Pediatric cotrimoxazole 0% 0% 7% 93% 
Dosing of pediatric ARVs 0% 0% 0% 100% 
Pediatric TB screening 21% 7% 14% 57% 
Routine HIV testing for children 
(N=12) 
100% 0% 0% 0% 
Adolescent support 
services(N=13) 
54% 8% 8% 31% 
Pediatric facility referral to 
community care and support 
services 
100% 0% 0% 0% 
TB/HIV 
Adult/Adolescent TB screening 21% 0% 29% 50% 
Isoniazid Prevention Therapy 
(IPT) (N=13) 
46% 23% 31% 0% 
Site/performance 
management (ART) 
Supportive supervision 50% 21% 14% 14% 
Site/performance 
management (ART – QM/QI 
system) 
HIV QM/QI System 29% 36% 21% 14% 
Assessment and Utilization of 
Performance Data 
36% 50% 14% 0% 
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Table 7-2 ART Monitoring 
Characteristic N (%) 
ART adherence measured 
                  Self-reported adherence 
                  Pill count 
                  Pharmacy refill records 
                  Other 
Individual who performs adherence measurement 
                  Provider 
                  Data clerk 
                  Community counselor 
Given current recommended patient booklet guidelines, adherence is difficult to measure (yes) 
                  Pill balance (under or over)* 
                  Not trained, difficult to quantify* 
Next step if patient reports missing doses of ARVs* 
                  Investigate 
                  Counseling 
                  Other 
Background of adherence counselor 
                  Community counselor 
                  Nurse 
Individual who performs adherence counseling is trained in ART adherence counseling (types include 
basic or refresher community or adherence counseling training*) 
                  Training in the past year 
                  Training more than five years ago 
Adherence counselor is available in ART clinic 
                  Every day 
                  2 days 
                  4 days 
Same day adherence counseling is available 
Adherence counseling job aids are used 
Adherence counseling is documented 
                  Patient booklet 
                  Patient passport 
Reasons patients cite poor ART adherence 
Forgot to take 
Other 
Stigma 
Not having food 
Alcohol related* 
Not having medications readily available 
Negative side effects 
Transportation issues* 
Tired of taking medication 
Feeling too sick 
Religious reasons* 
Challenges to delivering ART adherence counseling 
                   Managing poor adherence in children 
                  Healing manage patients underlying factors for poor adherence 
                  Increasing the patient’s understanding of the importance of taking ART 
                  Language barriers* 
                  Physical or human resource limitations* 
Measuring adherence 
What would help provide better/ more effective adherence counseling 
                  Training 
                  More job aids 
14 (100%) 
12 (86%) 
12 (86%) 
6 (43%) 
4 (29%) 
 
12 (86%) 
1 (7%) 
1 (7%) 
8 (57%) 
 
3 (43%) 
4 (57%) 
 
5 (36%) 
7 (50%) 
2 (14%) 
 
12 (92%) 
1 (8%) 
13 (93%) 
 
4 (36%) 
6 (55%) 
 
12 (86%) 
1 (7%) 
1 (7%) 
12 (86%) 
12 (86%) 
14 (100%) 
8 (57%) 
6 (43%) 
 
11 (79%) 
11 (79%) 
8 (57%) 
8 (57%) 
5 (36%) 
4 (29%) 
4 (29%) 
4 (29%) 
3 (21%) 
2 (14%) 
2 (14%) 
 
8 (57%) 
6 (43%) 
4 (29%) 
4 (29%) 
4 (29%) 
3 (21%) 
 
11 (79%) 
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Characteristic N (%) 
                  Additional human resources* 
                  Additional space, specific for adherence counseling* 
Another individual, other than the provider, conducts adherence counseling 
                  Community counselor 
                  Pharmacist 
                  Nurse 
Above individual received adherence training (answers included community and/or adherence 
counseling training and group trainings*) 
                  Training in the past year* 
                  Training more than five years ago* 
Routine information received for adherence counseling 
                  Patient booklet notes that indicate need/request for counseling 
                  Patient booklet notes that indicate potential barriers to adherence 
                  Patient passport notes that indicate need/request for counseling  
                  Patient passport notes that indicate potential barriers to adherence 
Information reviewed 
                  ART regimen 
                  Past visit dates 
                  Past adherence* 
                  Passport notes and referral reasons* 
                  VL history* 
Adherence counseling job aids are used 
Adherence counseling is documented 
Reasons patients cite poor ART adherence 
Transport issues* 
Other 
                  Forgot to take 
                  Not having medications readily available 
                  Not having food 
Don’t think medications do anything 
                  Stigma 
                  Alcohol related* 
Tired of taking medications 
                  Negative side effects 
Challenges to delivering ART adherence counseling 
                  Healing manage patients underlying factors for poor adherence 
                  Managing poor adherence in children 
                  Language barriers* 
                  Increasing the patient’s understanding of the importance of taking ART 
Measuring adherence 
What would help provide better/ more effective adherence counseling 
                  Training 
                 Link to community health care* 
More job aids 
                  Additional human resources*                
8 (57%) 
7 (50%) 
3 (21%) 
13 (93%) 
14 (100%) 
4 (29%) 
1 (7%) 
12 (92%) 
 
3 (27%) 
4 (36%) 
 
7 (54%) 
4 (31%) 
10 (77%) 
6 (46%) 
 
5 (38%) 
8 (62%) 
3 (23%) 
2 (15%) 
3 (23%) 
11 (85%) 
11 (85%) 
 
6 (55%) 
6 (55%) 
5 (45%) 
4 (36%) 
4 (36%) 
4 (36%) 
3 (27%) 
3 (27%) 
2 (18%) 
2 (18%) 
 
5 (45%) 
5 (45%) 
4 (36%) 
4 (36%) 
1 (9%) 
 
8 (73%) 
4 (36%) 
3 (27%) 
2 (18%) 
* Qualitative (open ended) responses and “other” responses were categorized with similar 
responses through inductive reasoning. 
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Table 7-3 Select Staffing type for ART clinic by Site 
Site Region 
Curren
t on 
ART 
# of 
physician
s 
# of 
RN 
# of 
EN 
# of data 
clerks 
Engela 
Ohangwen
a 
4889 1 4 2 3 
Katima Mulilo Zambezi 3526 0 3 1 3 
Katutura Health 
Centre 
Khomas 6144 2 6 2 3 
Katutura Int Hospital Khomas 6734 6 10 2 4 
Khomasdal Health 
Centre 
Khomas 895 2 1 0 1 
Nankudu Kavango 895 0 2 2 0 
Rundu Kavango 4318 2 4 2 2 
Onandjokwe Oshikoto 9271 1 5 3 4 
Ongwediva Health 
Centre 
Oshana 1850 0 6 4 1 
Oshakati Oshana 8127 4 6 4 5 
Oshikuku Omusati 3970 1 3 3 2 
Outapi Omusati 6822 1 3 4 3 
Tsandi Omusati 1630 1 3 0 1 
Okalongo Health 
Centre 
Omusati 2899 0 5 4 1 
 
Figure 7-1 Current ART Regimen Types in Adult Patients 
 
 
56%
28%
9% 6%
1%
TDF/3TC/NVP (1e)
TDF/3TC/EFV (1f)
AZT/3TC/NVP (1a/ 4b)
Other
AZT/3TC/LPV-r (99/ 4e)
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Figure 7-2 Current ART Regimen Types (%) in Pediatric Patients 
 
 
Table 7-4 : Last VL value (1 Dec 2013 to 30 Nov 2014) of Pediatric ART Patients by Site and Region (N=116) 
Region TOTAL VL 
within past 
12m 
VL < 1000 
n (%) 
VL > 1000 
n (%) 
Site TOTAL VL 
within past 
12m 
VL < 1000 
n (%) 
VL > 1000 
n (%) 
Ohangwena 
(N=10) 
7 (70%) 4 (57%) 3 (43%) Engela 7 (70%) 4 (57%) 3 (43%) 
Zambezi 
(N=10) 
4 (40%) 3 (75%) 1 (25%) Katima Mulilo 4 (40%) 3 (75%) 1 (25%) 
Khomas 
(N=20) 
18 (90%) 15 (83%) 3 (17%) Katutura HC 8 (80%) 8 (100%) 0 (0%) 
Katutura Hospital 10 (100%) 7 (70%) 3 (30%) 
Khomasdal HC (N=0) - - - 
Kavango 
(N=2) 
2 (100%) 0 (0%) 2 (100%) Nankudu (N=2) 2 (100%) 0 (0%) 2 (100%) 
Omusati 
(N=20) 
14 (70%) 9 (64%) 5 (36%) Okalongo HC 7 (70%) 5 (71%) 2 (29%) 
Tsandi 7 (70%) 4 (57%) 3 (43%) 
Oshikoto 
(N=10) 
9 (90%) 5 (56%) 4 (44%) Onandjokwe 9 (90%) 5 (56%) 4 (44%) 
Oshana* 
(N=14) 
14 (100%) 10 (71%) 2 (29%) Ongwediva HC (N=5) 5 (100%) 3 (60%) 2 (40%) 
Oshakati (N=9)* 9 (100%) 7 (78%) 0 (0%) 
Omusati 
(N=20) 
14 (70%) 9 (64%) 5 (36%) Oshikuku 8 (80%) 5 (63%) 3 (38%) 
Outapi 6 (60%) 4 (67%) 2 (33%) 
Kavango 
(N=10) 
10 (100%) 7 (70%) 3 (30%) Rundu 10 (100%) 7 (70%) 3 (30%) 
TOTAL 92 (79%) 62 (69%+) 28 (31%+) TOTAL 92 (79%) 62 (69%+) 28 (31%+) 
* Oshakati had documented VL dates but no documented VL value 
+ Denominator = 90 (number of patients with VL value) 
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Table 7-5 Viral Load Outcomes of Adult Patients with Repeat VL Results 
  
Last VL is 
<1000 (row %) 
Last VL is ≥ 1000 
(row %) 
No f/u VL (row 
%) 
TOTAL (column %) 
Initial VL <1000 103 (68%) 6 (4%) 43 (28%) 152 (73%) 
Initial VL ≥1000 28 (61%) 6 (13%) 12 (26%) 46 (22%) 
No Initial VL - - 10 (100%) 10 (5%) 
TOTAL (row %) 131 (63%) 12 (6%) 65 (31%) 208 
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